About
Biologic CDMO
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ResearchBiotech
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
591
By Phase
PHASE1: 3
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02314923Collaborator
Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)
PHASE1Completed
513 participants
Started: Dec 5, 2014 · Completed: Jun 23, 2016
NCT02269423Collaborator
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)
PHASE1Completed
39 participants
Started: Oct 13, 2014 · Completed: Aug 25, 2015
NCT02280408Collaborator
Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)
PHASE1Completed
39 participants
Started: Oct 7, 2014 · Completed: Dec 10, 2015
Locations (1)
Headquarters
Palo Alto, CA, United States
Map
Loading map...